Scopa James Paul
SEC CIK 1356950 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ALGS | Aligos Therapeutics, Inc. | Dir | 183.1K | — | — | 1 | 2023-10-25 | 2023-10-25 |
Most active insiders at ALGS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| No open-market trades in the last year. | ||||
Scopa James Paul made no open-market trades at ALGS in the last 12 months.
Transactions 1
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-10-27 | 2023-10-25 | ALGS | Aligos Therapeutics, Inc. | Scopa James Paul | Dir | A - Grant | $0.76 | +183.1K | 183.1K | New | +$139.1K |
Purchase Sale Sale after option exercise All abbreviations